Abstract: Intrauterine contraceptive devices and the progestin implant are the most effective long-acting reversible contraception (LARC) methods available for preventing unintended pregnancy. LARC devices are safe, non-user-dependent methods that have the highest rates of continuation and satisfaction of all reversible contraceptives. Use of these contraceptives remains low in the United States due to several barriers including: misperceptions among both providers and patients; cost barriers; and patient access to the devices. Increasing the opportunities for women to access LARC methods in the primary care, postabortion, and postpartum setting can be achieved by addressing the system, provider, and patient barriers that exist.
Introduction
Fifty-one percent of pregnancies in the United States are unintended, constituting a significant national health problem. 1, 2 Unintended pregnancy can have deleterious health consequences for both women and infants and incur high financial costs to the health system. 3 Increasing the provision of highly effective and easily accessible contraceptive methods is a strategy to combat this public health issue. 4 Long-acting reversible contraception (LARC) methods, including the intrauterine contraceptive device (IUD) and the single-rod progestin subcutaneous implant (implant) are the most effective reversible contraceptive methods available to date. LARC devices are safe, nonuser dependent, and easy to place after minimal provider training. 5 These methods have higher continuation rates after 1 year (>80%) than other reversible methods (49% to 57%) and are more cost-effective over time than other forms of contraception. [6] [7] [8] [9] A large, prospective cohort study conducted by the Contraceptive CHOICE Project at Washington University in St Louis (the CHOICE Project) found that women using pills, transdermal patch, or the vaginal ring had a risk of unintended pregnancy 20 times higher than women using an LARC method. 4 The CHOICE Project has also demonstrated that providing free access to LARC produced clinically significant reductions in abortion rates, repeat abortions, and teenage birth rates in the project area. 10 In addition to their high efficacy, LARC methods are safe options for all women of reproductive age with only rare exceptions. The literature shows that teens and nulliparous women can use LARC with few complications. Risks of pelvic inflammatory disease (PID), tubal infertility, and decreased bone mineral density among female teens and nulliparous IUD users remain low. 11, 12 In addition, the Centers for Disease Control and Prevention's (CDC) most recent report on US Selected Practice Recommendations for Contraceptive Use affirms that LARC can be used in almost all women of childbearing age as long as providers are reasonably certain that these patients are not already pregnant. 13 Despite the advantages noted above, these highly effective methods accounted for only 8.5% of contraceptives used by women in the United States in 2009. 14 A variety of barriers exist that constrain both the use and provision of LARC, including both patients' and providers' misinformation regarding their safety. 15 The need to ensure access to the most effective methods for preventing unintended pregnancies has become essential and integrating LARC provision into primary care as well as postabortion and postpartum settings is imperative (Fig. 1) . This article will summarize the existing data on LARC provision in these 3 clinical settings-primary care, postabortion care, and postpartum care-and address system-based, provider, and patient challenges to LARC provision so that any woman, any place, any time may receive these important health care services.
Primary Care

BACKGROUND
This section will outline issues influencing LARC provision in primary care settings and provide strategies to integrate LARC into comprehensive sexual and reproductive services. Obstetrician/gynecologists may serve as providers or consultants in a variety of primary care settings including obstetrics/gynecology clinics, private practice offices, community health centers, academic institutions, or schoolbased health centers. The changing health care environment presents challenges and opportunities for all primary care settings to provide LARC methods as an essential component of standard contraceptive services. 16 These guidelines not only serve Title X-funded agencies but also provide national standards for contraceptive services, including LARC provision.
For clinics offering IUD insertion that also provide emergency contraception, the copper IUD should be a first-line method. Effectiveness is greater than oral formulations and can be used for the first 5 days after unprotected sex. 17 Clinics can develop systems to enable provision of the copper IUD as emergency contraception. This could include workflow protocols to allot extra time on the schedule, counseling scripts, and ensuring adequate copper IUD and instrument stock.
Financial Barriers
Cost-sharing and copays for LARC are one of the largest barriers women face in accessing these methods. 18 There will be an increased demand for LARC as most women will be able to access contraception without cost-sharing under the Affordable Care Act contraceptive provision. As demonstrated by the CHOICE Project, three quarters of participants chose an IUD or implant-showing that when the cost barrier is removed, more women of all ages choose an LARC method. 10, 19 In addition, concerns about costeffectiveness regarding LARC use are not substantiated because switching from oral contraception to a LARC method can be cost-saving when used for a year or more. 20 Several strategies exist to address the cost barriers related to LARC. These include: (1) informing patients of the coverage available to avoid a perceived barrier; (2) educating providers regarding appropriate coding practice for improved billing; (3) seeking private foundation/donor support to offset costs; (4) advocating directly with insurance plans, both private and public to ensure all methods are covered as a key preventive health benefit; (5) advocating with payers to provide the full reimbursement as per the covered benefit policy; and (6) enlisting allies to assist in advocacy: the Office of Population Affairs, pharmaceutical companies, state health care finance agencies, or the National Family Planning and Reproductive Health Association. 21 
PROVIDERS
Counseling
An easy entry for discussing contraception and LARC with patients in primary care practice is the One Key Question (http://www.onekeyquestion.org): would you like to become pregnant in the next year? In this patient-centered counseling approach, a response of ''no'' can lead to further discussion about the patient's reproductive life plan. Patient-centered counseling should include a tiered counseling approach in which the most effective methods for preventing pregnancy are presented first. Tiered counseling tools such as those designed by the National Campaign to Prevent Teen and Unplanned Pregnancy at Bedsider.org and the CDC are key resources for discussing LARC effectiveness (Fig. 3) . Clinician counseling has been found to positively affect perception about IUDs among women seeking primary care services and can significantly improve contraceptive knowledge in general. [22] [23] [24] Increasing the frequency and quality of structured counseling by clinicians and nonclinicians can improve utilization rates of LARC. 25 For a more detailed description of contraceptive counseling, see the article by Dehlendorf et al 26 in this issue.
Management of Side Effects
Although discontinuation rates for both the IUD and implant are the lowest among all other reversible contraceptive methods, providers' perceptions about early discontinuation are often based on anecdotal evidence, and they may discourage use with their patients. 27, 28 Unpredictable bleeding and cramping are the most common reasons for removal of LARC methods with discontinuation 
Increasing LARC Utilization 721
rates for all reasons between 6% and 17%. 29, 30 The CHOICE Project found a discontinuation rate of <10% for LARC methods at 6 months with no significant difference among age groups. 31 Discussion of possible side effects before placement and active management of unscheduled bleeding during any followup visits is essential to ensure satisfied continuation and acceptance with any method.
8,32
Eligibility for LARC Insertion There are very few cases where a woman is not eligible for a LARC method. First, an IUD or implant insertion can be done at any point in the menstrual cycle as long as pregnancy is reasonably excluded. 13 No back-up methods are needed after insertion of the copper IUD, however, a backup method is recommended for 7 days after placement of the levonorgestrel IUD or implant unless inserted immediately postabortion, postpartum, or within 5 days of beginning menstruation. 13 Second, clinicians do not need to exclude women from receiving a LARC method who have a history of ectopic pregnancy or PID, are breastfeeding, are nulliparous, or adolescent. 13, 17 Current mucopurulent discharge, acute cervicitis, or pregnancy are examples of the few contraindications to IUD initiation. Other uncommon contraindications include copper allergy (specifically for the copper IUD), congenital uterine anomalies, or cervical or uterine malignancies. The levonorgestrel IUD and implant should not be initiated or continued when severe cirrhosis or breast cancer are present. 33 In addition, routine screening for sexually transmitted infections (STIs) in most circumstances is not needed before placing an IUD. For women who may be at higher STI risk, testing can be done the same day as the insertion and subsequent treatment given if needed, just as would be done for any other screening visit. For a detailed discussion of evidence-based STI testing at the time of IUD insertion, please see the paper by Sufrin and Averbach 34 in this issue. IUD removal is not required for a woman with a diagnosis of gonorrhea or chlamydia on antibiotic treatment or for a woman with PID as long as she is improving with treatment. If there is no improvement with appropriate antibiotic treatment, the IUD should then be removed. IUDs may also remain in place for endometrial biopsy, colposcopy, cervical biopsies, or saline-infused sonography. 35 Training and Insertion Practices LARC uptake in primary care depends on having willing and skilled clinicians for effective counseling and insertion. Obstetrics and Gynecology (ObGyn) residency training programs typically include LARC insertion; however, it is not always included in other training programs such as family medicine, pediatrics, midwifery, or advanced practice clinical training (nurse practitioner). Non-ObGyn clinicians and newer clinicians may benefit from experienced ObGyn mentors to become more skilled with insertions after initial training. Insertion challenges (cervical dilation issues, uterine perforation fears, or a distorted uterine cavity) can deter clinicians from including IUD placement in their practice. Training should include tips for dealing with complicated insertions, partial expulsion, case-based scenarios, and management of side effects (Tables 1-3) .
PATIENTS
First, misperceptions about LARC persist among patients, despite the large amount of evidence of their safety and effectiveness, which can lead to decreased use. 23, [36] [37] [38] Patients often have misconceptions about LARC devices leading to decreased use. 38 Various LARC patient educational tools and materials are available to address misperceptions, increase knowledge, and consequently increase patient demand for these devices. Providing patient brochures that outline the tiers of effectiveness, method options, and typical benefits and risks are a first step. Establishing patient educational videos in waiting room televisions or tablets could also be beneficial (see Table 4 for resources). Small demonstration models of the IUD and implant are important teaching tools that can be easily placed in examination rooms.
Addressing barriers that may deter adolescents from seeking LARC in a primary care setting is also important given that LARC methods are considered firstline options for this age group. 38 There are numerous strategies for provision of youth-friendly reproductive health services that may increase the use of LARC in this at-risk population (Fig. 4) . 39 Recent research from a national survey of publicly funded family planning sites found that youth-friendly facilities were significantly more likely to discuss LARC during a contraceptive teen visit, and LARC use is more likely to increase over time at youth-friendly facilities. 39 All contraceptive services for adolescents should be confidential and not require parental consent. 35, 40 City or state coalitions are another strategy to achieve greater impact, particularly for addressing special populations such as teens.
Postabortion Provision of LARC
BACKGROUND
Women who present for an abortion are an ideal group of patients for LARC use, as a LARC provision immediately following a first-trimester or second-trimester abortion has been proven safe and effective. [41] [42] [43] [44] Data from postabortion IUD insertions have shown a significantly lower rate of repeat abortions matched against controls using other non-IUD contraception. 45 Providing LARC insertions (IUD or implant) immediately after a surgical abortion or at the time of a postmedical abortion follow-up visit will enable women to obtain effective contraception without an additional appointment. For more information about postabortion contraception, please see the article by Micks et al 46 within this issue. Of note, the following chapter may also apply to patient care after spontaneous early pregnancy failure. 
Common Barriers for LARC Integration
Inadequate time and lack of protocols for same-day LARC insertions have been identified as significant clinic flow or systems barriers. 47 However, only a small amount of additional time is needed for the clinician to perform an insertion. 48, 49 Placement of an IUD after aspiration abortion takes approximately 1 minute, and typical implant placement requires less time. Although there are a few medical reasons to delay initiation of a LARC method, it is important for medical directors to develop appropriate protocols. These protocols should cover STI testing, consents before anesthesia, contraindications, indications for ultrasound use, and individual clinic considerations. Of note, STI testing of low-risk patients with no sign of clinical infection before LARC placement is unnecessary. 50, 51 (Please see Eligibility for LARC insertion section for further details.)
Complex components to immediate LARC provision at clinics offering abortion are cost-restriction policies. Indeed, high cost to patients is the major barrier to immediate postabortion LARC provision. 49 Abortion services in states where contraception-friendly policies and Medicaid family planning expansions exist are more likely to have LARC accessible. Policies that mandate the separation of state-funded contraception service organizations and organizations providing abortion services are particularly problematic. Understanding state and local policies and insurer billing codes is important, as well as paying close attention to payer reimbursements. External funding from foundations or private donations might offset high costs by providing critical subsidies to self-pay and uninsured patients. Clinic administrators need to work diligently and creatively to overcome cost barriers to provide this critical service.
PROVIDERS
Training
Clinicians who provide abortion services and clinic counselors need to be well versed in up-to-date information on LARC methods. Undertaking a balanced and dual approach is necessary. This includes combining safe, effective, compassionate abortion care with safe, effective contraceptive care. Clinicians also need support for obtaining the necessary training required to insert postabortion LARC. Ensuring all providers are trained in counseling and LARC placement is prudent and part of quality abortion service care. In addition, primary health care providers may be more likely to refer their patients in need of abortion services to practitioners who adeptly provide LARC methods as part of their practice.
An important and appealing consideration for both patients and providers is the reduction in pain for an IUD insertion in this setting. The cervix is already dilated utilizing anesthesia and no sounding is needed. Another LARC opportunity is at the follow-up appointment for a medical abortion. This appointment could also be used as a LARC method appointment. This would shift the emphasis of this visit toward effective contraception provision. Both IUDs and implants can be safely placed at this time with appropriate counseling regarding back-up methods for the first week following either an implant or hormonal IUD placement. 35 
PATIENTS
As noted above, LARC uptake has been slowly increasing in the United States, but many patients are still unaware of the efficacy of these contraceptive methods. 14 Multiple patient education strategies can be employed in clinics offering abortion services to improve patient awareness, knowledge, and the ability to make an informed choice. Such strategies include, but are not limited to: brochures or flyers written at the appropriate literacy level and produced by unbiased sources (Table 4) ; waiting room materials that promote the most effective methods with signs encouraging patients to ask questions; staff members wearing ''ask me about LARC'' buttons or posting similarly worded fliers; and having waiting room TV education.
Finally, providers should be aware that patients often need to hear information more than once to accept it. LARC conversations should be viewed as ''planting seeds'' and may need to occur over several encounters. Ideally these conversations are held before the abortion appointment, such as with the referring clinician. Many patients will leave without a LARC method, but all counseling should still be viewed as an important step toward reducing unintended pregnancies.
Postpartum Provision of LARC
BACKGROUND
The postpartum period is an important time in a woman's reproductive life to promote her health and the health of her newborn. Preventing unintended pregnancy in the 18 months following delivery is an important aspect in promoting the health of the newborn, maintaining and restoring maternal nutrition, and lowering risk of future preterm birth. 52 Health care providers play a pivotal role in providing contraception to women in the postpartum period and antiquated practices may be adding to short-interval and unintended pregnancies. In the first 12 months postpartum, the unintended pregnancy rate can be as high as 44%. 53, 54 It is the responsibility of prenatal care providers to ensure that appropriately spacing and planning a future pregnancy as well as nurturing the newborn is achieved through provision of effective contraceptive methods.
SYSTEMS
Many opportunities exist to provide LARC methods in the postpartum period and each must be maximized for maternal and neonatal health. Whether providing postplacental IUD insertion or inpatient implant placement, obstacles can be overcome with a systematic approach. A study 55 found several barriers to provision of LARC methods in the postpartum period, including 35% of patients not attending their postpartum visit. Providers of women's health care can take a variety of steps to help ensure postpartum care and contraception provision, including: scheduling the postpartum visit at 3 or 4 weeks instead of 6 weeks, providing postplacental IUDs and implants during the hospital stay, and using prenatal visits to create a plan for postpartum contraception method and initiation. 56 The Postpartum Hospital Stay Prenatal visits offer the opportunity to discuss and plan for LARC placement during the inpatient postpartum hospital stay. The hospital stay can then be an important opportunity to provide LARC methods as women may be motivated, and in the case of postplacental IUD placement, they may even have anesthesia in place. An implant may be placed at any point during the inpatient postpartum stay, whereas a postplacental IUD may be placed within 10 minutes after delivery of the placenta in either a vaginal or cesarean delivery. 57, 58 Further discussion regarding inpatient postpartum contraception can be found in the section by Sober et al. 59 For guidance regarding contraception in breastfeeding women, please see the Update to CDC's US Medical Eligibility Criteria for Contraceptive Use. 60 The Postpartum Visit Instead of waiting 6 to 8 weeks to see new mothers, this outdated habit should be changed and new mothers should be seen 3 or 4 weeks after they deliver to optimize postpartum health and lower the risk of an unintended pregnancy. Ideally, she will already have a postpartum visit scheduled before she leaves the hospital. This can be accomplished through staff training and appropriate discharge planning protocols, such as ensuring the patient has the postpartum appointment scheduling number. This paradigm shift in practice is important due to the possible return of ovulation and the potential for having resumed sexual activity before the historical 6-week visit. Notably, if the patient desires an IUD and cannot or does not receive a postplacental IUD, the postpartum visit should be scheduled at 4 weeks. 35 When making the postpartum appointment, scheduling staff should ask what the patient plans for contraception. This can allot extra appointment time and preparation of insurance authorization for LARC device placement if that is the chosen method (Fig. 2) . Having a plan already in place for postpartum contraception before the transition into parenthood can improve interval pregnancy spacing for healthy families.
Billing
Similar to other care settings, reimbursement is a common obstacle in providing LARC devices in the postpartum period. For patients with insurance coverage, the hospital is reimbursed by the insurer with a ''labor and delivery'' diagnosis-related group. The diagnosis-related group code will determine what the hospital receives for reimbursement as a specific, fixed amount for all of the services and therapies involved in their inpatient care, depending on the mode of delivery and the contract the insurance company has with the hospital. This does not allow for reimbursement of specific services or medical therapies such as factor VII, blood transfusions, or IUDs and implants. Despite this, several states (CA, NM, NY, SC) have been successful in influencing their state Medicaid offices to cover LARC devices in the postpartum period during the inpatient stay. This process can begin by contacting the hospital's billing department regarding a separate billing code for LARC devices during inpatient stays. There can be simple fixes such as a ''flag'' in the billing code or electronic medical record that signals separate billing. It is also useful to consider contract addenda with each insurance company to cover the devices. Working with hospital billing departments and local health departments can make a difference in reimbursement coverage for providing LARC devices during inpatient stays.
PROVIDERS
Counseling and the Prenatal Visit
The World Health Organization recommends a minimum of 18 months between pregnancies (from the date of delivery to the date of beginning to attempt the next pregnancy) to reduce maternal and neonatal risks of preterm delivery, low birth weight, fetal death, and small for gestational age. 52 Tiered counseling to discuss LARC first during prenatal care is recommended. 16 Contraceptive counseling during prenatal visits can be optimized in a variety of ways. For example, utilizing electronic medical record technology tools allow for the creation of checkboxes 
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ensuring all facets of prenatal counseling are covered, including postpartum contraception (see the Providers section under Primary care section). As a structured and routine point of contact, the prenatal period presents an opportunity for thoughtful discussion of many health care aspects, including postpartum contraception.
PATIENTS
Discussing all of the available contraceptive methods is no longer recommended. 16 Counseling can be overwhelming, but with the recommended tiered approach, it can be managed in a client-centered manner (Fig. 3 ). An important aspect of the method planning process is acknowledging that the provider's priority is not always the patient's priority. Informational brochures should be readily available so that patients and their partners can take them home to discuss. As the patient will be returning to the office throughout prenatal care, an on-going discussion can ensue to inform her and her partner regarding the most suitable method for their family planning priorities.
Conclusions
Unintended pregnancies remain at high and stagnant levels in the United States. Strong and continued evidence point to the effectiveness, safety, and convenience of LARC methods. ObGyn providers are positioned in multiple settings making them important players in family planning public health strategies to reduce these high rates of unintended pregnancies. Primary care, postabortion care, and postpartum settings are all likely avenues where ObGyn providers can have an impact. Continued efforts to modify clinic systems, train staff, and educate patients should be addressed to increase LARC utilization for any woman, any place, at any time.
